Annemiek Broijl has been a staff member of the Department of Hematology at the Erasmus MC Cancer Institute in Rotterdam, The Netherlands since 2013.

She was trained as a hematologist in the Department of Hematology at the Erasmus MC Cancer Institute, and obtained her PhD summa cum laude in 2012 with a thesis entitled ‘Molecular Profiling in Multiple Myeloma’ under the supervision of Professor Pieter Sonneveld.

Dr Broijl’s current activities are focused on organizing clinical trials in multiple myeloma with a strong correlative program. Her interest is mainly in the molecular characterization of the plasma cells, as well as the bone marrow micro-environment and adaptive immune system in the patient in order to identify disease and patient related factors involved in resistance/sensitivity to therapy.

She combines active patient care with translational studies in the Myeloma Research Lab. She has an active role in the national myeloma working group (MWG),  is a member of the international Myeloma Working Group (IMWG), and member and chairperson of the Young European  Myeloma Network (EMN) board.

Full publication list: link